COVID-19 Follow-up care paths and Long-term Outcomes Within the Dutch health care system: a combined rehabilitation, pulmonary, and intensive care perspective (CO-FLOW study)

  • Funded by Netherlands Organisation for Health Research and Development (ZonMW)
  • Total publications:0 publications

Grant number: 1.043E+13

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2023
  • Known Financial Commitments (USD)

    $548,359.81
  • Funder

    Netherlands Organisation for Health Research and Development (ZonMW)
  • Principal Investigator

    Pending
  • Research Location

    Netherlands
  • Lead Research Institution

    Erasmus Medical Center
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Subject

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Project description Background After hospital discharge, COVID-19 patients follow various aftercare paths, for example in a rehabilitation center, nursing home, or physiotherapy practice. We still know little about the eventual recovery after COVID-19 and the effect of these aftercare pathways. Target Mapping the long-term consequences of COVID-19 and further developing the aftercare paths. Method COVID-19 patients who have been admitted to hospital in Rotterdam-Rijnmond will be followed for 2 years. A lot of data is collected, such as patient flows, health care use and (predictors of) physical, cognitive and psychological recovery. What are the benefits? It is expected that patients who have experienced COVID-19 after hospital discharge may experience complaints in various areas for a long time. The research provides insight into the long-term consequences of COVID-19 and the aftercare is better tailored to the patient.